Investors
We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.
Fourth Quarter & Full Year 2025 Results
Fourth quarter and full year 2025 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.
Press Releases
Upcoming Events
23Apr
First Quarter 2026
First quarter 2026 results will be reviewed by management during a live audio webcast with the financial community on April 23, 2026. The presentation will be followed by a Q&A session.
Quarterly results
29Apr
Annual General Meeting 2026
The Sanofi General Meeting will be held on April 29, 2026 at the Palais des Congrès in Paris.
Annual general meetings
30Jul
Second Quarter 2026
Second quarter 2026 results will be reviewed by management during a live audio webcast with the financial community on July 30, 2026. The presentation will be followed by a Q&A session.
Quarterly results
30th Consecutive Year of Dividend Increase
Environment, Social, Governance
As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.
Contact Our Investor Relations Team
For general inquiries
Please contact the switchboard, +33 (0)1 53 77 40 00